← Open Payments lookup

BRET HAFEN: Open Payments

NPI 1982060828 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$217,976 in 493 payments from 11 companies in 2025. Trend: 2023 $42,690 · 2024 $116,914 · 2025 $217,976

Speaker / faculty: $162,389Travel & lodging: $34,000Consulting: $12,820Food & beverage: $8,762Education: $5
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)209$108,582
Alkermes, Inc.91$36,850
ABBVIE INC.95$29,881
Janssen Pharmaceuticals, Inc49$29,083
E.R. Squibb & Sons, L.L.C.27$7,598
Otsuka America Pharmaceutical, Inc.13$5,484
Janssen Scientific Affairs, LLC2$219
Neurocrine BioSciences, Inc.3$145
Otsuka Pharmaceutical Development & Commercialization, Inc.1$71
Neuronetics, Inc.2$47

Products named: CAPLYTA, LYBALVI, INVEGA SUSTENNA, VRAYLAR, ABILIFY MAINTENA, VIVITROL, REXULTI, COBENFY.

Industry payments across UT — which companies pay providers there.